Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AQST-109
- Development stage
- Unknown
- Lead developer
- Aquestive Therapeutics
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Hydrogel Systems → Drug Delivery Systems, Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Sublingual
01
Overview
AQST-109 (brand name Anaphylm) is a polymer matrix-based epinephrine prodrug formulated as a sublingual film for the rapid delivery of epinephrine. Designed to be applied under the tongue, it dissolves quickly without the need for water or swallowing and is intended for emergency treatment of allergic reactions including anaphylaxis. The product offers a needle-free alternative to traditional injectable epinephrine auto-injectors and aims to address barriers such as needle phobia and portability. The film is small (postage stamp-sized), lightweight, and packaged in a compact form that can withstand various environmental conditions[1][2][3][4].
- Brand names
- Anaphylm
- Other names
- Epinephrine oral film - Aquestive TherapeuticsEpinephrine sublingual film - Aquestive TherapeuticsEpinephrine sublingual soluble film - Aquestive Therapeutics
02
Targets
AR (Adrenergic receptors)
Beyond the preview
Go deeper on AQST-109.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AQST-109.